Light-Activated gel targets Pre-Cancerous skin spots

NCT ID NCT07144345

Ongoing Disease control Sponsor: Sun Pharmaceutical Industries, Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing a reformulated gel that is activated by a special blue light to treat rough, scaly spots caused by sun damage (actinic keratosis) on the face or bald scalp. About 160 adults with 4 to 8 of these spots will receive either the active gel or a placebo gel, followed by light treatment. The main goal is to see how many patients have all their spots completely cleared 12 weeks after treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Arlington Dermatology

Rolling Meadows, Illinois, 60008, United States
Center for Clinical and Cosmetic Research

Aventura, Florida, 33180, United States
Center for Dermatology Clinical Research, Inc

Fremont, California, 94538, United States
Medisearch, LLC

Saint Joseph, Missouri, 64506, United States
Minnesota Clinical Study Center

New Brighton, Minnesota, 55112, United States
Oregon Dermatology and Research Center

Portland, Oregon, 97210, United States
Palmetto Clinical Trial Services, LLC

Greenville, South Carolina, 29615, United States
Premier Clinical Research

Spokane, Washington, 99202, United States
Tennessee Clinical Research Center

Nashville, Tennessee, 37215, United States
The Indiana Clinical Trials Center, PC

Plainfield, Indiana, 46168, United States

Conditions

Explore the condition pages connected to this study.

ACTINIC KERATOSIS